2010
July 20, 2010
Ad Hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics AG: Licensee ARUP Laboratories Launches Septin9 Colorectal Cancer Blood Test in the United States
 PDF-file 31 kB
March 08, 2010
Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act): Epigenomics AG: PRESEPT Academic Research Study Meets Its Primary Objective
PDF-file 12 kB
January 15, 2010
Ad Hoc Announcement pursuant of §15 WpHG (German Securities Trading Act): Epigenomics AG Releases Preliminary PRESEPT Study Data
PDF-file 12 kB
January 10, 2010
Ad Hoc Announcement pursuant of §15 WpHG (German Securities Trading Act): Epigenomics AG: Licensing Partner Quest Diagnostics Introduces Colorectal Cancer Blood Test in the U.S.
PDF-file 12 kB
2009
December 21, 2009
Ad Hoc Announcement pursuant of §15 WpHG (German Securities Trading Act): Epigenomics AG: Strategic Partner Abbott Launches Colorectal Cancer Blood Test in Europe and Asia/Pacific
PDF-file 9 KB
October 05, 2009
Ad hoc (§15 WpHG): Epigenomics AG: Launches Colorectal Cancer Blood Test Epi proColon in Europe
PDF-file 11 kB
August 12, 2009
Ad hoc (§15 WpHG): Epigenomics AG: ARUP Laboratories
PDF-file 15 kB
March 25, 2009
Ad hoc (§15 WpHG): Epigenomics AG: Notice of Loss
PDF-file 12 kB
February 11, 2009
Ad hoc Announcement According to §15 WpHG (German Securities Trading Act): Epigenomics AG Increases Share Capital
PDF-file 12 kB
January 22, 2009
Ad hoc Announcement According to §15 WpHG (German Securities Trading Act): Epigenomics AG Signs Strategic R&D Collaboration Agreement in Colorectal Cancer with Sysmex Corporation
PDF-file 78 kB
2008
December 19, 2008
Ad hoc Announcement According to §15 WpHG (German Securities Trading Act): Epigenomics AG and Philips Collaborate on Integrated Automation Solutions for DNA Methylation-based Cancer Diagnostics
PDF-file 75 kB
November 18, 2008
Ad hoc Announcement According to §15 WpHG (German Securities Trading Act): Epigenomics AG and Abbott Molecular Inc. Expanded Strategic In Vitro Diagnostics Partnership
PDF-file 76 kB
February 19, 2008
Ad hoc ( § 15 WpHG): Epigenomics Licenses Septin 9 Colorectal Cancer Biomarker to Quest Diagnostics
PDF-file 86 kB
January 14, 2008
Ad hoc (§15 WpHG): Epigenomics AG Licenses Several Key Technologies to OncoMethylome Sciences S.A.
PDF-file 85 kB
2007
September 26, 2007
Ad hoc (§15 WpHG): Epigenomics AG Announces Strategic In Vitro Diagnostics Partnership with Abbott Molecular
PDF-file 52 kB
May 29, 2007
Ad hoc: Epigenomics AG Expands Partnership With QIAGEN N.V.
PDF-file 104 kB
May 4, 2007
Ad Hoc: Epigenomics AG Completes Capital Increase and Placement of New Shares
PDF-file 48 kB
May 3, 2007
Ad hoc: Epigenomcis AG Announces Capital Increase
PDF-file 47 kB
January 16, 2007
Ad hoc: Epigenomics AG appoints Senior Abbott Executive Geert Walther Nygaard as new CEO
PDF-file 92 kB
2006
December 15, 2006
Ad hoc: Epigenomics AG reviews all options for the commercialization of cancer screening test products after end of collaboration with Roche Diagnostics
PDF-file 108 kB
October 26, 2006
Ad hoc: Epigenomics AG: Focus on late stage product development
PDF-file 96 kB
August 17, 2006
Ad hoc: Board of directors, Epigenomics AG: Epigenomics announces change in the Executive Board
PDF-file 19 kB
July 21, 2006
Ad hoc: Epigenomics AG Decides Capital Increase - Affymetrix Signs For New Shares
PDF-file 26 kB
June 27, 2006
Ad hoc: Epigenomics AG and Affymetrix Announce Strategic Diagnostics Platform Agreement
PDF-file 26 kB
March 22, 2006
Ad hoc: Epigenomics AG Reports Extension of Blood Screening Product Collaboration
PDF-file 26 kB
March 10, 2006
Ad hoc: Epigenomics Confirms Lead Marker for Prediction of Breast Cancer Relapse
PDF-file 27 kB
January 30, 2006
Ad hoc: Epigenomics AG Pursuing Development of Tamoxifen Response Test
PDF-file 42 kB
January 4, 2006
Ad hoc: Epigenomics Successfully Completes Biomarker Validation Study for Prostate Cancer Classification Test
PDF-file 49 kB
2005
December 19, 2005
Ad hoc: Epigenomics DNA methylation test successfully detects colorectal cancer in blood
PDF-file 89 kB
December 13, 2005
Ad hoc: Milestone and licensing decision on tamoxifen response test postponed to end of January 2006
PDF-file 45 kB
November 15, 2005
Ad hoc: Epigenomics AG announces end of VC pooling
PDF-file 72 kB
October 31, 2005
Ad hoc: Epigenomics reports Tamoxifen treatment response test study results inconclusive
PDF-file 28 kB
September 30, 2005
Ad hoc: Epigenomics and Roche Diagnostics extend R&D collaboration agreement
PDF-file 44 kB
September 12, 2005
Ad hoc: Epigenomics AG announces resignation of Aron Braun
PDF-file 44 kB
August 15, 2005
Ad hoc: Retiring Epigenomics executive Gary Schweikhardt released from lock-up at year-end
PDF-file 44 kB
August 2, 2005
Ad hoc: Epigenomics AG announces Gary Schweikhardt to retire
PDF-file 29 kB
May 2, 2005
Ad hoc: Epigenomics and QIAGEN Enter into Strategic Collaboration in DNA Methylation
PDF-file 24 kB
January 20, 2005
Ad hoc: Epigenomics AG Announces End of Lock-Up Period
PDF-file 19,2 kB
2004
December 22, 2004
Ad hoc: Epigenomics AG Archieves Key Milestones in Development of Prostate Cancer Classification
PDF-file 80,9 kB
December 2, 2004
Ad hoc: Epigenomics AG and Roche Diagnostics Expand R&D Structure of Collaboration
PDF-file 19,2 kB
November 3, 2004
Ad hoc: Epigenomics AG Reports Third Quarter 2004 Results
PDF-file 20,4 kB
August 12, 2004
Ad hoc: Epigenomics AG Meets Key Milestone in Breast Cancer Test
PDF-file 19 kB
|
